However, similar to cytokines, findings for BDNF are variable across studies, likely due to small sample sizes, heterogeneous cancer types, differences in treatment regimens, timing of sample collection, and individual variability in systemic and CNS responses. This evidence concerns the gene BDNF and cancer.